YM BioSciences reports loss of $14.9 million in latest financial year

Via Acquire Media NewsEdge) MISSISSAUGA, Ont. _ YM BioSciences Inc. (TSX:YM) said Friday it lost $14.9 million in its most recent financial year as the company continued its drug development work. The Toronto-based company said the loss amounted to 27 cents per share for the financial year ended June 30 compared with a loss of $31.7 million or 57 cents per share the previous year. Revenue for the year was $7.4... [read full story]